$98.67 +0.90 (%) Cubist Pharmaceuticals Inc - NASDAQ

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Tetraphase Jumps As 'Superbug' Drug Scores In Trial

    IBD | Dec. 18, 2014 | 11:54AM EST
  2. Making Money With Charles Payne: 12/12/14

    FoxBusiness | Dec. 12, 2014 | 18:00PM EST
  3. Merck-Cubist deal going ahead

    IBD | Dec. 9, 2014 | 18:42PM EST
  4. Mizuho Securities Downgrades Cubist Pharmaceuticals Post Acquisition Announcement

    Benzinga | Dec. 9, 2014 | 12:14PM EST
  5. Merck-Cubist Deal Going Ahead Despite Patent Setback

    IBD | Dec. 9, 2014 | 11:27AM EST
  6. Hospira, Inc. Ticks Up On Favorable Patent Ruling vs. Cubist Pharmaceuticals Inc

    Benzinga | Dec. 9, 2014 | 11:09AM EST
  7. Pharmaceutical Giant Merck Buys Cubist Pharma

    GuruFocus | Dec. 9, 2014 | 11:04AM EST
  8. Stocks Hitting 52-Week Highs

    Benzinga | Dec. 9, 2014 | 10:00AM EST
  9. Merck & Co. Under Pressure Following Patent Ruling

    Benzinga | Dec. 9, 2014 | 09:30AM EST
  10. Cellceutix Corp Shares Rise On Two Catalysts

    Benzinga | Dec. 9, 2014 | 09:28AM EST
  11. Merck Bets $9.5 Billion On Cubist's War On Superbugs

    IBD | Dec. 8, 2014 | 18:49PM EST
  12. Merck Buys Super Antibiotics

    IBD | Dec. 8, 2014 | 18:47PM EST
  13. Energy Leads Stock Sell-Off

    IBD | Dec. 8, 2014 | 18:47PM EST
  14. Benzinga's M&A Chatter for Monday December 8, 2014

    Benzinga | Dec. 8, 2014 | 18:27PM EST
  15. Making Money With Charles Payne: 12/8/14

    FoxBusiness | Dec. 8, 2014 | 18:00PM EST
  16. 3 Biotech ETFs Rally On Merger News

    Benzinga | Dec. 8, 2014 | 17:43PM EST
  17. Mid-Afternoon Market Update: Dow Slides Over 100 Points; Oil Futures Down 4%

    Benzinga | Dec. 8, 2014 | 15:37PM EST
  18. Stocks Fall To Session Lows: GoPro Gives Up More Ground

    IBD | Dec. 8, 2014 | 13:25PM EST
  19. Mid-Day Gainers From December 8: Cubist Pharmaceuticals, Acceleron Pharma, Calithera Biosciences, Cempra, Isis Pharmaceuticals

    Benzinga | Dec. 8, 2014 | 13:00PM EST
  20. Mid-Day Market Update: McDonald's Drops On Weak November Sales; Acceleron Pharma Shares Jump

    Benzinga | Dec. 8, 2014 | 12:56PM EST
  21. Merck's CEO Doesn't Think That Valuations In The Biotech Industry Are 'Rich'

    Benzinga | Dec. 8, 2014 | 12:46PM EST
  22. Merck Acquiring Cubist, Focusing On Hospital Care

    IBD | Dec. 8, 2014 | 11:48AM EST
  23. Mid-Morning Market Update: Markets Mixed; Merck To Buy Cubist Pharmaceuticals For $102/Share

    Benzinga | Dec. 8, 2014 | 10:46AM EST
  24. Benzinga's Volume Movers

    Benzinga | Dec. 8, 2014 | 10:20AM EST
  25. Stocks Hitting 52-Week Highs

    Benzinga | Dec. 8, 2014 | 10:08AM EST
  26. Morning Market Movers

    Benzinga | Dec. 8, 2014 | 09:44AM EST
  27. Merck Aims at Superbugs with $9.5B Cubist Buy

    FoxBusiness | Dec. 8, 2014 | 09:42AM EST
  28. Pharmaceutical Stocks In Play Following Merck/Cubist Deal

    Benzinga | Dec. 8, 2014 | 09:09AM EST
  29. Stocks Set For Weak Start; Cubist Leaps On Buyout

    IBD | Dec. 8, 2014 | 08:48AM EST
  30. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 8, 2014 | 08:11AM EST
  31. US Stock Futures Point To Lower Open Monday

    Benzinga | Dec. 8, 2014 | 07:01AM EST
  32. Must Watch Stocks for December 8, 2014

    Benzinga | Dec. 8, 2014 | 04:32AM EST
  33. Benzinga's Weekend M&A Chatter

    Benzinga | Dec. 7, 2014 | 18:24PM EST
  34. Merck in Talks to Acquire Cubist for ~$100/Share

    Benzinga | Dec. 5, 2014 | 23:24PM EST
  35. UPDATE: Credit Suisse Downgrades Cubist Pharmaceuticals On Execution Risk To Global Expansion Of Hospital Franchise

    Benzinga | Nov. 20, 2014 | 08:11AM EST
  36. Is This Superbug Drug Company Right for Your Portfolio?

    FoxBusiness | Nov. 19, 2014 | 12:08PM EST
  37. Making Money With Charles Payne: 11/17/14

    FoxBusiness | Nov. 17, 2014 | 18:00PM EST
  38. Wedbush Initiates Coverage On Cubist Pharmaceuticals

    Benzinga | Nov. 4, 2014 | 11:09AM EST
  39. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  40. Benzinga's Weekend M&A Chatter

    Benzinga | Oct. 19, 2014 | 21:58PM EST
  41. Actavis expands antibiotics

    IBD | Oct. 6, 2014 | 18:45PM EST
  42. Actavis Expands Antibiotics Presence With Durata Buy

    IBD | Oct. 6, 2014 | 10:58AM EST
  43. Morning Market Losers

    Benzinga | Jul. 23, 2014 | 09:52AM EST
  44. Jefferies Raises Price Target On Cubist Pharmaceuticals

    Benzinga | Jun. 23, 2014 | 15:40PM EST
  45. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 23, 2014 | 08:07AM EST
  46. Cubist Readies For Takeoff With New Antibiotic Launch

    IBD | Jun. 19, 2014 | 17:23PM EST
  47. Cubist Pharma Reports Publicant of Pivotal Data from SIVEXTRO ESTABLISH-2 Trial

    Benzinga | Jun. 6, 2014 | 09:01AM EST
  48. Morning Market Movers

    Benzinga | Apr. 29, 2014 | 09:43AM EST
  49. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 29, 2014 | 08:09AM EST
  50. Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium

    GuruFocus | Apr. 23, 2014 | 16:46PM EST
Trading Center